Tightening of regulatory norms offers opportunity for Western suppliers'

摘要

Aesica Pharmaceuticals, UK-based provider of contract development and manufacturing services for APIs and finished dosage products to the pharmaceutical industry, sees the high levels of regulation, coupled with the continued evolution of the field, which has created challenges in the API manufacturing industry, as actually being a great opportunity to exhibit high quality and regulatory compliance best practice, and to continually increase confidence within the marketplace.